Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- DOI
- 10.1007/s40263-025-01232-1
- Published
- 2025-10-23
- Container
- CNS Drugs
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40263-025-01232-1,
title = {Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial},
author = {Hanrong Cheng and Liying Deng and Zili Meng and Wei Zhang and Tao Chen and Rui Chen and Shiyou Tang and Yunhui Lv and Xiaoli Su and Zhifen Liu and Xiaoqing Zhang and Xueyi Wang and Hongjing Mao and Nuofu Zhang and Huan Yu and Jiyang Pan and Yuping Xie and Jiyou Tang and Shankai Yin and Zan Wang and Maoqing Tong and Shuqin Zhan and Chunxue Wang and Bei Wang and Weihua Zhang and Weifeng Mi and Lin Lu},
year = {2025},
journal = {CNS Drugs},
doi = {10.1007/s40263-025-01232-1},
url = {https://doi.org/10.1007/s40263-025-01232-1}
}RIS
TY - JOUR TI - Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial AU - Hanrong Cheng AU - Liying Deng AU - Zili Meng AU - Wei Zhang AU - Tao Chen AU - Rui Chen AU - Shiyou Tang AU - Yunhui Lv AU - Xiaoli Su AU - Zhifen Liu AU - Xiaoqing Zhang AU - Xueyi Wang AU - Hongjing Mao AU - Nuofu Zhang AU - Huan Yu AU - Jiyang Pan AU - Yuping Xie AU - Jiyou Tang AU - Shankai Yin AU - Zan Wang AU - Maoqing Tong AU - Shuqin Zhan AU - Chunxue Wang AU - Bei Wang AU - Weihua Zhang AU - Weifeng Mi AU - Lin Lu PY - 2025 JO - CNS Drugs DO - 10.1007/s40263-025-01232-1 UR - https://doi.org/10.1007/s40263-025-01232-1 ER -
APA
Cheng, H., Deng, L., Meng, Z., Zhang, W., Chen, T., Chen, R., Tang, S., Lv, Y., Su, X., Liu, Z., Zhang, X., Wang, X., Mao, H., Zhang, N., Yu, H., Pan, J., Xie, Y., Tang, J., Yin, S., Wang, Z., Tong, M., Zhan, S., Wang, C., Wang, B., Zhang, W., Mi, W., & Lu, L. (2025). Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial. CNS Drugs. https://doi.org/10.1007/s40263-025-01232-1
Source records
- crossref · retrieved 2026-09-24T23:48:58.740Z